Bilan biologique de 59 cas de pneumopathies aiguës atypiques

por Ghanassia, J.P., Avril, M.F., Vezinet, F., Modai, J.
Publicado 1979

Sorafenib in advanced melanoma: a critical role for pharmacokinetics?

por Pécuchet, N, Lebbe, C, Mir, O, Billemont, B, Blanchet, B, Franck, N, Viguier, M, Coriat, R, Tod, M, Avril, M-F, Goldwasser, F
Publicado 2012

The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanoma

por Lesueur, F, de Lichy, M, Barrois, M, Durand, G, Bombled, J, Avril, M-F, Chompret, A, Boitier, F, Lenoir, G M, Bressac-de Paillerets, B
Publicado 2008

Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study.

por Avril, M. F., Auperin, A., Margulis, A., Gerbaulet, A., Duvillard, P., Benhamou, E., Guillaume, J. C., Chalon, R., Petit, J. Y., Sancho-Garnier, H., Prade, M., Bouzy, J., Chassagne, D.
Publicado 1997

First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanoma

por Le Tourneau, C, Dreno, B, Kirova, Y, Grob, J J, Jouary, T, Dutriaux, C, Thomas, L, Lebbé, C, Mortier, L, Saiag, P, Avril, M F, Maubec, E, Joly, P, Bey, P, Cosset, J M, Sun, J S, Asselain, B, Devun, F, Marty, M E, Dutreix, M
Publicado 2016

Association of MC1R Variants and Host Phenotypes With Melanoma Risk in CDKN2A Mutation Carriers: A GenoMEL Study

por Demenais, F., Mohamdi, H., Chaudru, V., Goldstein, A. M., Newton Bishop, J. A., Bishop, D. T., Kanetsky, P. A., Hayward, N. K., Gillanders, E., Elder, D. E., Avril, M. F., Azizi, E., van Belle, P., Bergman, W., Bianchi-Scarrà, G., Bressac-de Paillerets, B., Calista, D., Carrera, C., Hansson, J., Harland, M., Hogg, D., Höiom, V., Holland, E. A., Ingvar, C., Landi, M. T., Lang, J. M., Mackie, R. M., Mann, G. J., Ming, M. E., Njauw, C. J., Olsson, H., Palmer, J., Pastorino, L., Puig, S., Randerson-Moor, J., Stark, M., Tsao, H., Tucker, M. A., van der Velden, P., Yang, X. R., Gruis, N.
Publicado 2010